HCG and Immunofluorescent Assays

Overview of hCG and Related Pathologies

  • Discussion on causes of lower and higher than expected hCG levels.

Causes of Lower than Expected hCG

  • Ectopic Pregnancy:

    • Definition: A condition where a fertilized egg implants outside the uterus, often in a fallopian tube.

    • Implication: Results in lower than expected levels of hCG due to improper fetal development.

  • Divided Urine:

    • Clarification: Not within the current analysis context.

  • Miscarriage:

    • Definition: The spontaneous loss of a fetus before the 20th week of pregnancy.

    • Implication: Causes reduced hCG production as the pregnancy voids.

Causes of Higher than Expected hCG

  • Multiple Pregnancies:

    • Definition: The condition of carrying more than one fetus (e.g., twins, triplets).

    • Implication: Increases the total hCG levels due to multiple placentas producing the hormone.

  • Choriocarcinoma:

    • Definition: A malignant tumor of the uterus that arises from trophoblastic cells.

    • Implication: Produces elevated hCG levels as part of the cancer's pathology.

  • Testicular Tumors:

    • Definition: Tumors occurring in one or both testicles; may secrete hCG.

    • Implication: Some cancers can lead to the production of hCG in men, influencing diagnostic results.

  • Drugoblastic Disease:

    • Definition: A type of disease characterized by abnormal growth of trophoblastic tissue.

    • Implication: Leads to increased levels of hCG in the bloodstream.

Interpretation of hCG Assay Results

  • Result Validity:

    • Invalid Result:

    • Reason: No control line present, indicating quality control failure.

    • Negative Result:

    • Reason: Control line present without test line indicating absence of hCG.

    • Positive Result:

    • Reason: Presence of both control and test lines indicates hCG is present in the sample.

Immunofluorescent Assays Overview

  • Direct Immunofluorescent Assay:

    • Procedure:

    • Collect patient tissue (e.g., biopsy).

    • Apply specific antibody conjugate to the tissue on a slide to detect antigens.

    • Wash and visualize with a fluorescent microscope; the presence of fluorescence confirms antigen presence.

  • Indirect Immunofluorescent Assay:

    • Procedure:

    • Apply commercial antigen on slide.

    • Add patient serum that may contain antibodies.

    • Introduce a second labeled antibody to bind to patient antibodies, wash, and visualize with a fluorescent microscope.

    • Context: Often used in Antinuclear Antibody (ANA) Tests for diagnosing autoimmune diseases.

    • Implication: Helps identify autoantibodies present in autoimmune disorders.

Assay Types and Principles

  • Fluorescence Polarization Imaging Assay:

    • Homogeneous vs. Heterogeneous:

    • Homogeneous Assay: All components added together without washing.

    • Assay Type:

    • Competitive Assay: Involves interaction where labeled antigen competes with patient antigen for binding to antibody.

    • Working Principle:

    • Small labeled antigen tumbles quickly in solution, causing scattered light polarization.

    • When the antibody binds to the labeled antigen, complex size increases, reducing its ability to tumble quickly, leading to increased polarized light in one direction.

    • Outcomes:

    • Increased polarization corresponds with the presence of patient antigen due to reduced free labeled antigen in the solution.

    • Clarification on how the presence of patient antigen creates competitive binding, influencing assay readouts.